Baxter International Inc. (BAX)
Automate Your Wheel Strategy on BAX
With Tiblio's Option Bot, you can configure your own wheel strategy including BAX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BAX
- Rev/Share 21.2222
- Book/Share 14.2164
- PB 1.6406
- Debt/Equity 1.3286
- CurrentRatio 2.2964
- ROIC -0.0012
- MktCap 12023869038.0
- FreeCF/Share 0.6491
- PFCF 36.1077
- PE -77.4795
- Debt/Assets 0.4621
- DivYield 0.029
- ROE -0.0212
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | BAX | Stifel | Buy | Hold | -- | $25 | Aug. 4, 2025 |
| Downgrade | BAX | Goldman | Buy | Neutral | -- | $25 | Aug. 1, 2025 |
| Resumed | BAX | Goldman | -- | Buy | -- | $42 | Feb. 26, 2025 |
| Upgrade | BAX | Argus | Hold | Buy | -- | -- | Feb. 24, 2025 |
| Resumed | BAX | Barclays | -- | Overweight | -- | $39 | Feb. 20, 2025 |
News
Will BAX's Q1 Earnings Improve Following Transformation Completion?
Published: April 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.
Read More
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
Published: April 10, 2025 by: Business Wire
Sentiment: Neutral
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe. “For over a decade, Hemopatch Sealing Hemostat.
Read More
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
Published: April 10, 2025 by: Business Wire
Sentiment: Neutral
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe. “For over a decade, Hemopatch Sealing Hemostat.
Read More
Kontoor Brands CEO Scott Baxter sits down with Jim Cramer
Published: February 20, 2025 by: CNBC Television
Sentiment: Neutral
Kontoor Brands Chair, President, and CEO Scott Baxter joins 'Mad Money' host Jim Cramer to talk acquiring Helly Hansen, international business, and more.
Read More
BAX Stock Surges Following Q4 Earnings & Sales Beat, Margins Decline
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Baxter reports better-than-expected fourth-quarter results. However, the company's gross and operating margins contract.
Read More
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript
Published: February 20, 2025 by: Seeking Alpha
Sentiment: Neutral
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript
Read More
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook
Published: February 20, 2025 by: Benzinga
Sentiment: Positive
On Thursday, Baxter International Inc. BAX reported a fourth-quarter 2024 adjusted EPS of 58 cents, beating the management guidance of 50 cents-53 cents and the Wall Street estimate of 52 cents.
Read More
Baxter (BAX) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Baxter to Present at Raymond James & Associates' 46th Annual Institutional Investors Conference
Published: February 17, 2025 by: Business Wire
Sentiment: Neutral
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Monday, March 3, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:05 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Saturday, August 30, 2025. About Baxter Every day, millions of.
Read More
Baxter Declares Quarterly Dividend
Published: February 11, 2025 by: Business Wire
Sentiment: Neutral
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on April 1, 2025, to stockholders of record as of Feb. 28, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of dia.
Read More
About Baxter International Inc. (BAX)
- IPO Date 1981-10-27
- Website https://www.baxter.com
- Industry Medical - Instruments & Supplies
- CEO David Brent Shafer
- Employees 38000